TTS PHARMA company contrib to 13873- KTP: Prospecting hemp extract as an innovative anti-inflammatory therapy for porcine and equine mating-induced endometritis

Prosiect: Ymchwil a ariannwyd yn allanol

Manylion y Prosiect

StatwsWedi gorffen
Dyddiad cychwyn/gorffen dod i rym01 Awst 202131 Gorff 2023

Cyllid

  • TTS Pharma Ltd (98015): £104,172.17